SEC Fines MusclePharm For Unreported Executive Perks, Disclosure Gaps
This article was originally published in The Tan Sheet
Executive Summary
The firm, which recently appointed a board chairman as founder and CEO Brad Pyatt moved out of the post in a restructuring, agrees to a $700,000 fine and to make management changes including hiring an independent monitor for one year.
You may also be interested in...
US DoJ Has 'Key Focus' On Supplement Industry, Adds 6 Attorneys To Sector
Supreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade Complaint
The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly 200 appeals to consider decisions in civil litigation and convictions in criminal cases. However, Amarin still eyes curbing competition from omega-3 supplements.
US Senate Passes First Monograph Reform Bill After House Passed Three
Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by the same title on its floor for a vote since it was passed by Energy and Commerce Committee in late June.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: